LENZ Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: LENZ · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1815776
| Field | Detail |
|---|---|
| Company | Lenz Therapeutics, Inc. (LENZ) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
LENZ Therapeutics is asking shareholders to vote on key company matters.
AI Summary
On June 10, 2025, LENZ Therapeutics, Inc. filed an 8-K to report on the submission of matters to a vote of security holders. The filing indicates that the company is seeking shareholder approval for certain corporate actions.
Why It Matters
This filing signals that LENZ Therapeutics is proceeding with important corporate decisions that require shareholder consent, potentially impacting the company's future direction and governance.
Risk Assessment
Risk Level: low — This is a routine filing to inform about a shareholder vote, not an event that inherently increases risk.
Key Players & Entities
- LENZ Therapeutics, Inc. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters being submitted for a vote, only that such matters are being presented.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 10, 2025.
What is the exact name of the registrant?
The exact name of the registrant is LENZ Therapeutics, Inc.
In which state was LENZ Therapeutics, Inc. incorporated?
LENZ Therapeutics, Inc. was incorporated in Delaware.
What is the Commission File Number for LENZ Therapeutics, Inc.?
The Commission File Number for LENZ Therapeutics, Inc. is 001-40532.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding LENZ Therapeutics, Inc. (LENZ).